FDA-approved disulfiram as a novel treatment for aggressive leukemia

M Karsa, L **ao, E Ronca, A Bongers… - Journal of Molecular …, 2024 - Springer
Acute leukemia continues to be a major cause of death from disease worldwide and current
chemotherapeutic agents are associated with significant morbidity in survivors. While better …

Star Polymer Nanomedicines─ challenges and future perspectives

H Forgham, J Zhu, R Qiao, TP Davis - ACS Applied Polymer …, 2022 - ACS Publications
Star polymers are structures composed of multiple functional linear arms covalently
connected through a central core. The unique conformation of star polymers, with their …

Targeting metabolic dependencies in pediatric cancer

SH Issaq, CM Heske - Current opinion in pediatrics, 2020 - journals.lww.com
Current Opinion in Pediatrics Log in or Register Subscribe to journalSubscribe Get new
issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation …

Mitochondrial metabolism: powering new directions in acute myeloid leukemia

RJ Stubbins, IA Maksakova, DS Sanford… - Leukemia & …, 2021 - Taylor & Francis
There has been an explosion of knowledge about the role of metabolism and the
mitochondria in acute myeloid leukemia (AML). We have also recently seen several waves …

Potent antileukemic activity of curaxin CBL0137 against MLL‐rearranged leukemia

K Somers, A Kosciolek, A Bongers… - … Journal of Cancer, 2020 - Wiley Online Library
Around 10% of acute leukemias harbor a rearrangement of the MLL/KMT2A gene, and the
presence of this translocation results in a highly aggressive, therapy‐resistant leukemia …

Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin

M Karsa, A Kosciolek, A Bongers, A Mariana… - British Journal of …, 2021 - nature.com
Background The prognosis for high-risk childhood acute leukaemias remains dismal and
established treatment protocols often cause long-term side effects in survivors. This study …

Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemia

K Somers, K Evans, L Cheung, M Karsa, T Pritchard… - Leukemia, 2020 - nature.com
The prognosis for children diagnosed with high-risk acute lymphoblastic leukemia (ALL)
remains suboptimal, and more potent and less toxic treatments are urgently needed. We …

Oncogenic and tumor suppressor function of MEIS and associated factors

B Gİrgİn, MK ALPASLAN… - Turkish Journal of …, 2020 - journals.tubitak.gov.tr
MEIS proteins are historically associated with tumorigenesis, metastasis, and invasion in
cancer. MEIS and associated PBXHOX proteins may act as tumor suppressors or …